hydroxyprogesterone caproate
Active substance: hydroxyprogesterone caproate
INJECTION · HYDROXYPROGESTERONE CAPROATE 250 mg/mL
United StatesActive
Marketing holder: Fresenius Kabi Austria GmbH
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- HYDROXYPROGESTERONE CAPROATE · 250 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12097-d858-7dbd-8ed8-8208ff00db3f,01a1209b-34cd-723a-a651-09b2f2a0312f;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 18124-016
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 18124-016 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 18124-016 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 18124-016 · Verified 2026-10-09 · open in source